MedPath

ShearWaveβ„’ Elastography of Breast Lesions in Chinese Patients

Completed
Conditions
Breast Neoplasms
Registration Number
NCT02226081
Lead Sponsor
SuperSonic Imagine
Brief Summary

We aim to determine if adding ShearWave Elastography to a standard ultrasound breast exam can improve the characterization (classification) of breast lesions.

Detailed Description

Chinese women are known to have denser breasts than women in Western countries. Mammography cannot find abnormalities easily in denser breasts, while breast ultrasound is not affected by density. Adding elastography, a stiffness measurement, to a breast ultrasound exam should improve the diagnosis of a lesion.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
2273
Inclusion Criteria
  • female

  • 18 years of age or older

  • known breast lesion that has not been managed or treated

  • referred for a breast ultrasound because of a breast mass found on at least one of the following examinations:

    • physical palpation
    • mammography
    • ultrasound exam
    • MRI
Exclusion Criteria
  • Women who are unwilling or unable to provide informed consent
  • Women with breast implants
  • Women who are pregnant or breastfeeding
  • Women in whom all lesions are diagnostically categorized as BI-RADS 0, 1 or 6
  • Women with previous ipsilateral breast surgery
  • Women with no visible breast mass on ultrasound examination
  • Women with axillary metastatic lymph nodes only
  • Women with foreign body in the breast
  • Women who are not Chinese nationality

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Increase in specificity of breast ultrasound imaging when considering stiffness measurementsWithin 18 months of the study start date
Secondary Outcome Measures
NameTimeMethod
Change of sensitivity and negative predictive value of breast ultrasound imaging when considering stiffness measurementsWithin 18 months of the study start date
Increase in positive predictive value for biopsy of breast ultrasound when considering stiffness measurementswithin 18 months of the study start date

Trial Locations

Locations (22)

Sichuan Provincial People's Hospital

πŸ‡¨πŸ‡³

Chengdu, China

Fujian Provincial Cancer Hospital

πŸ‡¨πŸ‡³

Fuzhou, China

1st Affiliated Hospital of PLAGH (304)

πŸ‡¨πŸ‡³

Beijing, China

People's Liberation Army General Hospital (301)

πŸ‡¨πŸ‡³

Beijing, China

1st Affiliated Hospital of Zhengzhou University

πŸ‡¨πŸ‡³

Zhengzhou, China

Fudan University Cancer Center

πŸ‡¨πŸ‡³

Shanghai, China

4th Affiliated Hospital of China Medical University

πŸ‡¨πŸ‡³

Shenyang, China

Hefei 2nd People's Hospital

πŸ‡¨πŸ‡³

Hefei, China

West China Hospital, Sichuan University

πŸ‡¨πŸ‡³

Chengdu, China

Yinzhou People's Hospital

πŸ‡¨πŸ‡³

Ningbo, China

Shengjing Hospital of China Medical University

πŸ‡¨πŸ‡³

Shenyang, China

General Hospital of TISCO

πŸ‡¨πŸ‡³

Taiyuan, China

Shanxi Dayi Hospital

πŸ‡¨πŸ‡³

Taiyuan, China

Jiangsu Provincial Hospital

πŸ‡¨πŸ‡³

Nanjing, China

1st Affiliated Hospital of Xi'an Jiaotong University

πŸ‡¨πŸ‡³

Xi'an, China

Beijing Friendship Hospital, Capital Medical University

πŸ‡¨πŸ‡³

Beijing, China

Affiliated Hospital of Binzhou Medical University

πŸ‡¨πŸ‡³

Binzhou, China

Guangdong Provincial Traditional Chinese Medical Hospital

πŸ‡¨πŸ‡³

Guangzhou, China

Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University

πŸ‡¨πŸ‡³

Guangzhou, China

Sun-Yat Sen University Cancer Center

πŸ‡¨πŸ‡³

Guangzhou, China

1st Affiliated Hospital of Harbin University

πŸ‡¨πŸ‡³

Harbin, China

1st Affiliated Hospital of China Medical University

πŸ‡¨πŸ‡³

Shenyang, China

Β© Copyright 2025. All Rights Reserved by MedPath